SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-333540
Filing Date
2017-11-06
Accepted
2017-11-06 07:06:03
Documents
3
Period of Report
2017-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d482751d8k.htm 8-K 14394
2 EX-99.1 d482751dex991.htm EX-99.1 534817
3 GRAPHIC g482751g1104040643634.jpg GRAPHIC 2526
  Complete submission text file 0001193125-17-333540.txt   554103
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 171178214
SIC: 2834 Pharmaceutical Preparations